CID 135456190

Eplivanserin

Structural Information

Molecular Formula
C19H21FN2O2
SMILES
CN(C)CCO/N=C(/C=C/C1=CC=C(C=C1)O)\C2=CC=CC=C2F
InChI
InChI=1S/C19H21FN2O2/c1-22(2)13-14-24-21-19(17-5-3-4-6-18(17)20)12-9-15-7-10-16(23)11-8-15/h3-12,23H,13-14H2,1-2H3/b12-9+,21-19-
InChIKey
VAIOZOCLKVMIMN-PRJWTAEASA-N
Compound name
4-[(E,3Z)-3-[2-(dimethylamino)ethoxyimino]-3-(2-fluorophenyl)prop-1-enyl]phenol
Related CIDs

2D Structure

compound 2d structure
6
Annotation Hits

61
References

2906
Patents

328.1587 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 329.16598 178.8
[M+Na]+ 351.14792 183.7
[M-H]- 327.15142 184.9
[M+NH4]+ 346.19252 192.5
[M+K]+ 367.12186 180.0
[M+H-H2O]+ 311.15596 168.6
[M+HCOO]- 373.15690 202.7
[M+CH3COO]- 387.17255 217.2
[M+Na-2H]- 349.13337 180.8
[M]+ 328.15815 179.7
[M]- 328.15925 179.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe